Insights into Ancestral Diversity in Parkinson’s Disease Risk: A Comparative Assessment of Polygenic Risk Scores

Paula Saffie-Awad, Mary B Makarious, Inas Elsayed, Arinola O. Sanyaolu, Peter Wild Crea, Artur F Schumacher Schuh, Kristin S Levine, Dan Vitale, Mathew J Koretsky, Jeffrey Kim, Thiago Peixoto Leal, María Teresa Periñan, Sumit Dey, Alastair J Noyce, Armando Reyes-Palomares, Noela Rodriguez-Losada, Jia Nee Foo, Wael Mohamed, Karl Heilbron, Lucy Norcliffe-Kaufmann, Mie Rizig, Njideka Okubadejo, Mike A Nalls, Cornelis Blauwendraat, Andrew Singleton, Hampton Leonard, Ignacio F. Mata, Sara Bandres-Ciga, the Global Parkinson’s Genetics Program (GP2) the 23andMe Research Team
doi: https://doi.org/10.1101/2023.11.28.23299090

Article Information

doi 
https://doi.org/10.1101/2023.11.28.23299090
History 
  • May 9, 2024.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Paula Saffie-Awad, MD1,2,3,
  2. Mary B Makarious, BSc4,5,
  3. Inas Elsayed, PhD6,
  4. Arinola O. Sanyaolu, PhD7,
  5. Peter Wild Crea, BSc4,8,
  6. Artur F Schumacher Schuh, MD, PhD1,9,10,
  7. Kristin S Levine, MS8,11,
  8. Dan Vitale, MS8,11,
  9. Mathew J Koretsky, BSc8,
  10. Jeffrey Kim, BA4,8,
  11. Thiago Peixoto Leal, PhD12,
  12. María Teresa Periñan, PhD13,14,15,
  13. Sumit Dey15,
  14. Alastair J Noyce15,
  15. Armando Reyes-Palomares16,
  16. Noela Rodriguez-Losada, PhD17,
  17. Jia Nee Foo18,19,
  18. Wael Mohamed, MD, PhD20,
  19. Karl Heilbron, PhD21,
  20. Lucy Norcliffe-Kaufmann, PhD21,
  21. the 23andMe Research Team,
  22. Mie Rizig5,15,
  23. Njideka Okubadejo22,
  24. Mike A Nalls, PhD4,8,11,
  25. Cornelis Blauwendraat, PhD4,8,
  26. Andrew Singleton, PhD4,8,
  27. Hampton Leonard, MS4,8,11,23,
  28. Ignacio F. Mata, PhD12,#,
  29. Sara Bandres-Ciga, PhD6,*,#,
  30. the Global Parkinson’s Genetics Program (GP2)
  1. 1Programa de Pós-Graduação em Ciências Médicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
  2. 2Centro de Trastornos del Movimiento (CETRAM), Santiago, Chile
  3. 3Clínica Santa María, Santiago, Chile
  4. 4Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
  5. 5Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom
  6. 6Faculty of Pharmacy, University of Gezira, Wadmadani, 20, Sudan
  7. 7Department of Anatomy, College of Medicine, University of Lagos, Nigeria
  8. 8Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814
  9. 9Serviço de Neurologia, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
  10. 10Departamento de Farmacologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
  11. 11DataTecnica LLC, Washington, DC, USA
  12. 12Genomic Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
  13. 13Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain
  14. 14Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
  15. 15Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK
  16. 16Department of Molecular Biology and Biochemistry, Faculty of Sciences, University of Málaga, Málaga, Spain
  17. 17Faculty of Education Sciences, University of Málaga, Málaga, Spain
  18. 18Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore
  19. 19Laboratory of Neurogenetics, Genome Institute of Singapore, A*STAR, Singapore, Singapore
  20. 20Neuroscience Unit, Clinical Pharmacology Dept., Menoufiia Medical School, Egypt
  21. 2123andMe, Inc., Sunnyvale, CA, USA
  22. 22Department of Medicine, College of Medicine, University of Lagos, Nigeria
  23. 23German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
  1. ↵*Corresponding author:
    Sara Bandres Ciga, Center for Alzheimer’s Disease and Related Dementias (CARD), National Institute on Aging (NIA), National Institutes of Health (NIH), 9000 Rockville Pike, NIH Building T44, Bethesda, MD 20892. Email: sara.bandresciga{at}nih.gov, Phone: +1 (301) 841-5095
Back to top
Posted May 09, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Insights into Ancestral Diversity in Parkinson’s Disease Risk: A Comparative Assessment of Polygenic Risk Scores
Paula Saffie-Awad, Mary B Makarious, Inas Elsayed, Arinola O. Sanyaolu, Peter Wild Crea, Artur F Schumacher Schuh, Kristin S Levine, Dan Vitale, Mathew J Koretsky, Jeffrey Kim, Thiago Peixoto Leal, María Teresa Periñan, Sumit Dey, Alastair J Noyce, Armando Reyes-Palomares, Noela Rodriguez-Losada, Jia Nee Foo, Wael Mohamed, Karl Heilbron, Lucy Norcliffe-Kaufmann, Mie Rizig, Njideka Okubadejo, Mike A Nalls, Cornelis Blauwendraat, Andrew Singleton, Hampton Leonard, Ignacio F. Mata, Sara Bandres-Ciga, the Global Parkinson’s Genetics Program (GP2)
medRxiv 2023.11.28.23299090; doi: https://doi.org/10.1101/2023.11.28.23299090
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area